LupusTrials.org The purpose of this randomized, double blind, placebo-controlled study is to evaluate the safety and efficacy of filgotinib and GS-9876 in participants with active Cutaneous Lupus Erythematosus. The trial is sponsored by Gilead Sciences, Inc.
To Learn More Contact
GS-US-436-4092@gilead.com
ClinicalTrials.gov identifier: NCT03134222